Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer.

Kristen D WhitakerXiaoliang WangMustafa AschaTimothy N ShowalterHeather G LewinGregory S CalipLori J Goldstein

Published in: Breast cancer research and treatment (2022)

These findings suggest that among patients with HR+HER2- mBC, NHB patients had worse survival beyond front-line setting, mainly among the subset of women who did not receive CDKi at 1L. This inequities in rwOS between race/ethnicity groups was not observed among patients who received 1L CDKi.

Keyphrases

metastatic breast cancer
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
polycystic ovary syndrome
type diabetes
african american
replacement therapy
breast cancer risk